News & Events

Oasis Diagnostics® Presenting at the First Asia-Pacific Saliva Symposium

January 17, 2017

Oasis Diagnostics® is proud to have CEO Paul Slowey presenting a lecture on “Advancements in Salivary Diagnostics Through Novel Collection Technologies” at the First Asia-Pacific Saliva Symposium. Dr. Slowey is joined by a cadre of other big names in the field…

Read More

Oasis Diagnostics® Supports the IADR Annual Symposium

November 29, 2016

Oasis Diagnostics® is proud to sponsor the Workshop on “Human Saliva Banking Workshop (IgA as a diagnostic tool) in 3rd Annual Conference of Pak Association for Dental Research (IADR Pakistan Section) at Dow Institute of Biotechnology and Biomedical Sciences (DRIBBS)….

Read More

Oasis Diagnostics® Preparing for MEDICA 2016

November 3, 2016

Oasis Diagnostics® will be exhibiting at the 2016 MEDICA Tradefair this year in booth D15-5. Oasis’ own CEO Paul Slowey will be joined by Central Region/International Sales Rep Peter van Arkens and together they will be showing off the latest…

Read More

Oasis Diagnostics® Supports the Present and Future of Salivary Diagnostics Workshop / Saliva Camp

October 7, 2016

Oasis Diagnostics® is proud to sponsor the Present and Future of Salivary Diagnostics: Workshop / Saliva Camp at the Universidade Católica Portuguesa in Viseu, Portugal. The event sees a range of presentations and speakers covering topics such as “Worldwide view of Salivary Research” (Dr,…

Read More

Oasis Diagnostics® Supports the PHSRG Workshop at CMH Lahore Medical and Institute of Dentistry

August 11, 2016

Oasis Diagnostics® is proud to sponsor the Workshop on “Human Saliva Banking and Proteins Analysis for Disease Detection” at CMH Lahore Medical and Institute of Dentistry, Lahore, Pakistan. The event sees a range of presentations and speakers covering topics such…

Read More

Oasis Diagnostics® Supports the PHSRG Workshop at the National Center for Proteomics

August 3, 2016

Oasis Diagnostics® is proud to sponsor the Workshop on “Human Saliva Banking and Proteins Analysis for Disease Detection” at National Center for Proteomics, Karachi University, Pakistan. The event sees a range of presentations and speakers covering topics such as “Human…

Read More

Molzym – Pathogen Genomics Product Line

February 16, 2017

Oasis Diagnostics™ Corporation now represents a unique line of technologies for human DNA removal and fungal / bacterial DNA enrichment and isolation from the progressive German company Molzym.  Molzym’s proprietary products allow for ultra-sensitive DNA detection of bacteria and fungi through…

Read More

Operon S.A. Molecular Diagnostic Product Line

February 1, 2015

  Oasis Diagnostics Corporation now represents the line of immunochromatography, molecular biology, monoclonal antibody, and recombinant antigen products from Operon S.A.  Operon is a leading company in technology and “in vitro” diagnostic products, with a solid reputation.  The Molecular Biology area in Operon…

Read More

BioTechniques Publishes: RNAPro•SAL: A device for rapid and standardized collection of saliva RNA and proteins

February 13, 2015

In a collaboration between Oasis Diagnostics® Corporation and the UCLA School of Dentistry, a paper has been released covering the effective use of the RNAPro•SAL™ Oral Specimen Collection System. The paper discusses the lack of a suitable collection and extraction system, and…

Read More

Oasis Diagnostics offers innovation in medical analysis

October 15, 2014

Vancouver Business Journal – October 03, 2014 Paul Slowey came a long way to start a Vancouver company that sells diagnostic medical equipment all around the world. His Oasis Diagnostics Corporation sells saliva collecting and testing tools that help medical…

Read More

Oasis Diagnostics® Announces Grant Award from the Michael J. Fox Foundation for Parkinson’s Disease

January 10, 2014

[OASIS] is the recipient of a research award from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to validate OASIS’ development of a non-invasive, saliva-based, rapid test for Parkinson’s disease detection and diagnosis. OASIS will collaborate with Dr. Charles…

Read More

Oasis Diagnostics Secures $1.3 Million in Phase II Funding from NIH for Its Rapid Saliva Test for Stress

August 22, 2013

Award of a $1.3 Million Dollar Grant for Saliva Stress Test Development Vancouver, WA (PRWEB) August 13, 2013 — Oasis Diagnostics® Corporation, a leader in the development and commercialization of oral sample collection systems for nucleic acids, proteins and small…

Read More

City of Vancouver profiling Oasis Diagnostics®

August 24, 2012
Read More

Dentistry space: the story of the principle

July 30, 2012

When I was a child I dreamed like many others of becoming an astronaut, and I kept that dream alive as an adult: it is still inside of me, strong and irresistible. So begins the story of Balwant Rai, one of…

Read More

Oasis Diagnostics Obtains Grant from NIH for Rapid Saliva-Based Test for Stress

July 9, 2012

Oasis Diagnostics has received a grant from NIH to develop a point of care test that will determine from saliva specimens how stressed an individual is, in 15 minutes or less. Oasis Diagnostics will collaborate with the University of New…

Read More

Oasis Diagnostics to Develop Saliva Test for Alzheimer’s, Parkinson’s

July 9, 2012

Oasis Diagnostics Corp has licensed technology for the non-invasive diagnosis of Alzheimer’s disease and Parkinson’s disease from Drs. Balwant Rai and Jasdeep Kaur. Using a series of proprietary biomarkers, Oasis will develop a rapid saliva test for these debilitating diseases…

Read More

PubTalk marks two years – The Columbian

November 12, 2011

Southwest Washington PubTalk marked its two-year anniversary Thursday evening with progress reports from leaders of six locally connected startups who had been featured speakers in earlier PubTalk sessions. More than 130 people attended the business networking event at the Fort…

Read More

PubTalk marks two years – The Columbian

November 12, 2011

Southwest Washington PubTalk marked its two-year anniversary Thursday evening with progress reports from leaders of six locally connected startups who had been featured speakers in earlier PubTalk sessions. More than 130 people attended the business networking event at the Fort…

Read More

Oasis Diagnostics to Develop Saliva Test for Alzheimer’s, Parkinson’s

September 29, 2011

Oasis Diagnostics Corp. has licensed technology for the non-invasive diagnosis of Alzheimer’s disease and Parkinson’s disease from Drs. Balwant Rai and Jasdeep Kaur. Using a series of proprietary biomarkers, Oasis will develop a rapid saliva test for these debilitating diseases…

Read More

Oasis Diagnostics Obtains Grant from NIH for Rapid Saliva-Based Test for Stress

September 14, 2011

Oasis Diagnostics has received a grant from NIH to develop a point of care test that will determine from saliva specimens how stressed an individual is, in 15 minutes or less. Oasis Diagnostics will collaborate with the University of New…

Read More

Spit Leads to Cancer Detection Breakthrough?

January 20, 2011

Oasis Diagnostics® Versi•SAL® is features in FOX 11 News video report. Spit Leads to Cancer Detection Breakthrough?: MyFoxLA.com

Read More

Amarillo Biosciences and Oasis Diagnostics® Sign License and Supply Agreement for Dietary Supplement Maxisal®

January 14, 2011

Amarillo, Texas, January 14, 2011 — Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) and Oasis Diagnostics® Corporation today announced that they have entered into an agreement under which Oasis will exclusively market Maxisal®, ABI’s dietary supplement for enhancement of salivary function,…

Read More

Oasis Diagnostic Secures Investment Award

April 3, 2009

Oasis Diagnostics® Corporation has received an investment award from a noted organization devoted to helping visionary entrepreneurs in the Pacific Northwest. Oasis was selected by the Zino Society from among 12 candidates whose commitment to new technology stands out in…

Read More

New Rapid Field Test for Tuberculosis

January 15, 2008

With TechLink assistance, Bamburgh Marrsh (BAMA) of Vancouver, Washington, has licensed a Navy-developed technology for rapid tuberculosis diagnosis using oral fluids (saliva). BAMA was founded in 2002 specifically for the purpose of pioneering new applications using novel saliva-based diagnostic systems….

Read More

New Defense Against Bioterrorism

January 15, 2008

The latest defense against bioterrorism may use your own saliva. A new toothbrush-sized field test developed by the Navy provides a rapid, inexpensive way to determine protection levels against anthrax. A test strip samples saliva and changes color within minutes…

Read More